Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-1-2022

Maternal nicotine exposure induces congenital heart defects in
the offspring of mice
Elizabeth R. Greco
Anish Engineer
Tana Saiyin
Xiangru Lu
Meng Qi Zhang

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Greco, Elizabeth R.; Engineer, Anish; Saiyin, Tana; Lu, Xiangru; Zhang, Meng Qi; Jones, Douglas L.; and
Feng, Qingping, "Maternal nicotine exposure induces congenital heart defects in the offspring of mice"
(2022). Paediatrics Publications. 1209.
https://ir.lib.uwo.ca/paedpub/1209

Authors
Elizabeth R. Greco, Anish Engineer, Tana Saiyin, Xiangru Lu, Meng Qi Zhang, Douglas L. Jones, and
Qingping Feng

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/1209

Received: 25 January 2022

|

Revised: 16 March 2022

|

Accepted: 1 April 2022

DOI: 10.1111/jcmm.17328

ORIGINAL ARTICLE

Maternal nicotine exposure induces congenital heart defects in
the offspring of mice
Elizabeth R. Greco1 | Anish Engineer1 | Tana Saiyin1 | Xiangru Lu1 |
MengQi Zhang1 | Douglas L. Jones1,2 | Qingping Feng1,2
1
Department of Physiology and
Pharmacology, London, Ontario, Canada
2

Department of Medicine, Schulich School
of Medicine and Dentistry, Western
University, London, Ontario, Canada
Correspondence
Qingping Feng, Department of Physiology
and Pharmacology, Schulich School
of Medicine and Dentistry, Western
University, London, Ontario, Canada.
Email: qfeng@uwo.ca
Funding information
This study was supported in part by the
Canadian Institutes of Health Research
(CIHR) and by Richard and Jean Ivey Fund.
QF holds a Richard and Jean Ivey Chair
in Molecular Toxicology, Schulich School
of Medicine and Dentistry, Western
University.

Abstract
Maternal cigarette smoking is a risk factor for congenital heart defects (CHDs).
Nicotine replacement therapies are often offered to pregnant women following failed
attempts of smoking cessation. However, the impact of nicotine on embryonic heart
development is not well understood. In the present study, the effects of maternal
nicotine exposure (MNE) during pregnancy on foetal heart morphogenesis were studied. Adult female mice were treated with nicotine using subcutaneous osmotic pumps
at 0.75 or 1.5 mg/kg/day and subsequently bred with male mice. Our results show
that MNE dose-dependently increased CHDs in foetal mice. CHDs included atrial and
ventricular septal defects, double outlet right ventricle, unguarded tricuspid orifice,
hypoplastic left ventricle, thickened aortic and pulmonary valves, and ventricular hypertrophy. MNE also significantly reduced coronary artery size and vessel abundance
in foetal hearts. Moreover, MNE resulted in higher levels of oxidative stress and altered the expression of key cardiogenic regulators in the developing heart. Nicotine
exposure reduced epicardial-to-mesenchymal transition in foetal hearts. In conclusion, MNE induces CHDs and coronary artery malformation in mice. These findings
provide insight into the adverse outcomes of foetuses by MNE during pregnancy.
KEYWORDS

congenital heart defects, embryonic heart development, maternal nicotine exposure, nicotine
replacement therapy
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I NTRO D U C TI O N

extensively and attributed to many toxins found in the tobacco
smoke. In the United States, United Kingdom and Australia, ap-

Congenital heart defects (CHDs) are the most common birth
1

proximately 12%–15% of women still smoke during pregnancy. 5

defect occurring in about 1% of live births. While genetic fac-

Annually in Canada, 75,000 newborns are affected by maternal

tors are identified in about 15% of cases, the cause of most

smoking, and in Northern Canada, as high as 59% of the newborns

CHDs (85%) remains unknown and may include environmental

are impacted. 6 Although many pregnant women may appreciate

2

Maternal cigarette smoking is an environmental risk

the danger of smoking, cessation is challenging because nicotine

factor for CHDs as well as other congenital anomalies. 3,4 The

is the highly addictive and only 46%–5 4% abstain from smoking

human adverse effects of cigarette smoking have been examined

during pregnancy.7,8

factors.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
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To reduce the prevalence of maternal smoking, pharmacothera-

subcutaneously, releasing nicotine at 0.75 or 1.5 mg/kg/day. These

pies such as nicotine replacement therapies (NRTs) are often offered

doses mimic a light smoker, of 1–10 cigarettes per day. 27–29 Control

to pregnant women following failed attempts at smoking cessa-

mice did not receive pump implantation. Fourteen days after im-

tion.9,10 Another popular method for smoking cessation is nicotine

plantation of the pump, the females were bred overnight in cages

containing electronic cigarettes (e-cigarettes). In young adults of

with healthy males, then returned to their original cage in the morn-

reproductive age (20–28), the use of e-cigarettes is rapidly increas-

ing. The presence of a vaginal plug indicated embryonic day (E) 0.5.

ing.11,12 Although NRTs and e-cigarettes contain nicotine, they are

Females that had an unsuccessful pregnancy following the presence

perceived to be less harmful than cigarette smoking since they do

of the plug were bred again with males. After 2 unsuccessful preg-

not contain additional toxins found in tobacco smoke. The relation-

nancies, females were sacrificed and not included in analysis.

ship between NRTs/e-cigarettes and congenital anomalies is poorly

Embryos from pregnant mice with or without maternal nico-

understood. Additional studies are required to elucidate the nico-

tine exposure (MNE) were collected at E10.5 to E18.5 via caesar-

tine's effects on foetal development.13 Currently available clinical

ean section under ketamine (50 mg/kg, IP) and xylazine (10 mg/kg,

evidence on the foetal safety of maternal use of NRTs during preg-

IP) anaesthesia. Dams were sacrificed by cervical dislocation after

14–17

nancy is discordant.

It remains unclear whether these replace-

ments are safe for the foetuses.

embryos were collected. Embryonic/foetal hearts were harvested
at E10.5 to analyse mRNA and oxidative stress during embryonic

Maternal nicotine exposure (MNE) during pregnancies is more

development; at E12.5 to analyse epicardial EMT potential, and at

likely to have adverse outcomes.18 In animal studies, MNE adversely

E18.5 to analyse morphology and mRNA. For mRNA analysis, hearts

affects various organs during foetal development, including exacer-

were flash frozen in liquid nitrogen and stored at −80°C freezer.

bation of fibrosis of lungs and kidney, alterations in brain structure
and function, mitochondrial dysfunction in the pancreas and impairment of structure and function of the placenta.19 In foetal hearts,

2.2 | Osmotic mini pumps

nicotine delays the development of the sinoatrial node and induces
cardiac arrhythmia. 20,21 Further, nicotine reduces blood oxygenation

Alzet (#2004) 28-day osmotic minipumps were prepared 24 h prior

and increases blood pressure in foetuses.18

to implantation. The online Alzet pump calculator was used to deter-

Increases in oxidative stress may contribute to these detrimental effects of foetal nicotine exposure.

22

mine the dose with which to fill the pump with nicotine ((-)-nicotine

Reactive oxygen species

N3876, Sigma-Aldrich) solution according to the weight of the ani-

(ROS) such as superoxide and hydrogen peroxide mediate many fun-

mal. An intramuscular injection of a mixture of ketamine (25 mg/ml),

damental cellular processes critical to embryonic development in-

xylazine (2.5 mg/ml) and atropine (30 µg/ml) was used to anaesthe-

cluding cell differentiation, proliferation, migration and programmed

tize the mice for surgical pump implantation. A small incision was

cell death.

23,24

Elevated ROS levels induce oxidative stress, which

made slightly posterior to the scapulae, and the pump was implanted.

alters genetic expression and disrupts developmental processes. In

The incision was closed with silk sutures, with the mice monitored

foetal hearts, oxidative stress contributes to the pathogenesis of

throughout recovery. To relieve pain, buprenorphine (0.05 mg/kg,

CHDs and coronary artery malformation. 25,26 To our knowledge,

s.c., q8h) was used for 2 days postsurgery.

there is no report on the direct effects of MNE on the pathogenesis of CHDs. We hypothesized that MNE during pregnancy would
impair foetal heart development, resulting in CHDs and hypoplastic

2.3 | Histological Analysis of CHD

coronary arteries. We tested this hypothesis using subcutaneous
osmotic pumps administering clinically relevant doses of nicotine to

Neonates (P0) and foetuses at E17.5 and E18.5 were collected for

female mice during gestation.

histological analysis. To collect foetuses, pregnant mice were anaesthetized with an intramuscular injection anaesthetic mixture (as

2

|
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2.1 | Animals

above), and a caesarean section was performed.30 The upper torso
of foetal and neonatal mice were isolated and immediately fixed in
4% paraformaldehyde for 18 h at 4 °C, then dehydrated in ethanol
and embedded in paraffin. Samples were serially sectioned at 5 μm
thickness using a Leica RM2255 microtome. Transverse sections

This study used mice in accordance with the Guide to Care and Use

started at the level of the thymus (just above the aortic arch) and

of Animals of the Canadian Council of Animal Care and was approved

continued until after the apex of the heart. Heart sections were

by the Animal Care Committee at Western University, Canada.

stained with haematoxylin/eosin (H/E) to diagnose CHDs during

C57Bl/6 mice were purchased from Charles River Laboratories,

blinded examination under a light microscope (Zeiss Observer D1,).

Canada. All efforts were made to minimize the number of animals

All quantifications of histological images were performed using ZEN

used and to minimize their suffering. Animals were housed in a 12 h

microscope software (Zeiss). The diameters of the proximal left and

light/dark cycle and had access to standard chow and water. Females

right coronary arteries were measured at 50 μm from the left coro-

at 8–10 weeks of age had osmotic pumps (Alzet #2004,) implanted

nary artery ostium and on a section 250 μm below the left coronary

|
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artery ostium where the right coronary artery was the most prominent, respectively.

2.4 | Immunohistochemistry

3225

2.7 | Analysis of superoxide, lipid peroxidation and
cell proliferation
Frozen E10.5 hearts from both control and MNE groups were
sectioned into 8 μm sections using a cryostat (CM1950, Leica).
Dihydroethidine (DHE, 2 μM), a molecular probe for superoxide, was

E18.5 foetal heart sections were immunostained using anti-
α-

used to measure relative levels of ROS by quantifying fluorescence

smooth muscle actin primary antibody (1:3000 dilution, Abcam,) to

densitometry in the absence or presence of 100 units/ml of superox-

visualize coronary arteries.31 Sections were blocked in a solution of

ide dismutase (SOD). Fluorescence was imaged using a microscope

0.3% H2O2 diluted in phosphate buffered saline (PBS) prior to incu-

(Observer D1, Zeiss). Three to 5 images were taken from 5 differ-

bation in secondary antibody. The primary antibody was left on over-

ent sections per heart sample at a fixed exposure time. AxioVision

night at room temperature in a humidity chamber. The secondary

Microsoft software (Observer D1, Zeiss) was used to quantify the

antibody, biotinylated goat anti-rabbit IgG (1:500) (Vector laborato-

signal intensity per area of myocardium.

ries), was subsequently left on sections for 1 h at room temperature

Lipid peroxidation, another indicator of cellular oxidative stress,

in a humidity chamber. All antibodies were diluted in tris-buffered

was measured in E10.5 frozen heart sections. Slides were incubated

saline with Tween-20 (TBST). Sections were then incubated in ABC

with anti-4-hydroxynonenal (4-HNE) primary antibody (1:300, Abm,

reagent (1:200 in PBS, Vector Laboratories) for 40 min and visual-

Vancouver, Canada) overnight at room temperature. A fluorescent-

ized using 3–3’ di-aminobenzidine tetrahydrochloride (DAB, Sigma-

labelled donkey anti-
goat secondary antibody (1:1000, LI-
COR

Aldrich,) and H2O2. All immunostained sections were counterstained

Biosciences) used to visualize lipid peroxidation, was incubated

with Mayer's Hematoxylin (Thermo Fisher Scientific).

for 1 h and followed by Hoechst stain (1:1000) to label the nuclei.
Images were taken at a constant exposure in heart sections of all

2.5 | Three-dimensional reconstruction of
coronary arteries

groups using a fluorescence microscope (Observer D1, Zeiss). The
fluorescence intensity was quantified using the AxioVision program
(Zeiss).
Anti-
phosphorylated histone H3 (pHH3) antibody (1:1000,

E18.5 serial heart sections 25 μm apart were immunostained with

Abcam) was used for detection of phosphorylated histone H3, a

α-smooth muscle actin to visualize coronary arteries. Images were

marker specific for cells undergoing mitosis, in E10.5 frozen heart

taken using a Zeiss Observer D1 microscope and processed with

sections. The primary antibody was left on for 2 h at room tempera-

the AMIRA® software (Template Graphics Software) to reconstruct

ture in a humidity chamber. Sections were then incubated for 1 h

three-dimensional (3D) model representations. The compact myo-

in secondary antibody (1:1000, Cy™3-conjugated AffiniPure Goat

cardium, and the right and left ventricles or coronary arteries were

Anti-Rabbit IgG, Jackson ImmunoResearch Laboratories), followed

labelled manually in each section. The volume of the labelled com-

by Hoechst stain (1:1000) to label nuclei. The number of proliferat-

ponents was calculated, and a ratio of coronary artery to myocardial

ing cells were quantified from the fluorescence signals.

volume was obtained.

31

2.6 | Real-time PCR analysis

2.8 | Epicardial EMT assay
To determine the effect of nicotine on epicardial epithelial-
to-

E10.5 and E18.5 hearts were isolated and snap frozen in liquid nitro-

mesenchymal transition (EMT), ventricles of E12.5 embryos were

gen. Total RNA was extracted from ventricular tissues of E10.5 and

harvested, cut into smaller fragments, and plated on the hydrated

E18.5 hearts using the TRIzol reagent method. Reverse transcription

collagen gel. M199 medium (Sigma-
Aldrich) was then added to

with M-MLV reverse transcriptase (Invitrogen, Canada) was per-

the culture either with or without nicotine (100 ng/ml, (-)-nicotine

formed using 0.2 µg of total RNA in a reaction mixture totaling 20 µl .

N3876 Sigma-Aldrich). After 3 days, images were captured using a

Following reverse transcription, real-time quantitative PCR ampli-

phase contrast microscope (Observer D1, Zeiss), and the number of

fication was performed using EvaGreen qPCR MasterMix (Abm,

spindle-shaped cells which had grown outward from the explanted

Vancouver, Canada). Primers were designed to amplify the genes

ventricles were quantified as previously described. 26,31

Nkx2.5, Gata4, Bmp10, eNOS, Notch1, CyclinD1, Hif-1α, bFGF, Tbx5,
Tbx18, Snail1, Slug, ALDH1a2, TGF-β1, PKCi, β-MHC, BNP, SX and 28S
(Table S1). An Eppendorf MasterCycler Realplex (Eppendorf) was

2.9 | In utero Echocardiography

used to amplify qPCR mixtures for 35 cycles at temperatures set in
accordance with the primer melting temperatures. The Ct values of

Directly prior to pup collection, foetal heart function was measured

target genes were normalized to 28S ribosomal RNA using a com-

at E18.5 using ultrasound imaging (Vevo 2100) with an MS 750 trans-

parative Ct method.

ducer (VisualSonics).32 Maternal mice were pre-
anaesthetized in a

3226
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F I G U R E 1 Effects of MNE (1.5 mg/kg/day) on foetal body weight, placental weight, pregnancy rate, cardiac function and CHD sex ratio.
Foetal weight (A), placental weight (B) and foetal/placental weight ratio (C) at E17.5 in control (n = 14) and nicotine (n = 29) groups. (D)
Fertility rate (number of successful pregnancies to total vaginal plugs). Left ventricular ejection fraction (E) and fractional shortening (F) were
determined using echocardiography in utero at E18.5. (G) Percent of male and female foetuses with or without a CHD. An unpaired Student's
t-test (A-C , E and F) or chi-squared test (D and G) was performed for statistical analysis. *p < 0.05, **p < 0.01 vs. control

chamber, using 3.0% isoflurane, and subsequently secured in the su-

differences in the CHD incidence and the DHE data. A p value less

pine position on a heated dock (temperature 37°C) with their noses

than 0.05 was considered statistically significant.

in a cone used to deliver 0.5–1.5% isoflurane (for anaesthesia maintenance). An incision was made on the lower abdomen to expose the
embryotic sacs. M-mode echocardiography images of the foetal hearts
were recorded in the short-axis view. The end-diastolic left ventricular internal diameter and end-systolic left ventricular internal diameter
were measured. Ejection fraction and fractional shortening were cal-

3
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3.1 | Effects of MNE on foetal weight, placental
weight, fertility rate and cardiac function

culated. Mothers were then anaesthetized with the same mixture as
above, and removed from isoflurane for pup collection.

Foetuses and placenta were weighed at collection. While the weight
of placenta was similar between control and MNE (1.5 mg/kg/day)

2.10 | Statistical analysis

groups (p=n.s), foetal weights and foetal-to-placental weight ratios
were significantly lower with MNE (p < 0.05, Figure 1A–C). The rate
of successful pregnancy (the per cent of vaginal plugs that lead to a

Data are presented as means ± SEM. Statistical analysis was per-

successful pregnancy) was lower in MNE (1.5 mg/kg/day) in com-

formed between control and MNE using unpaired Student's t-test

parison with controls (p < 0.01, Figure 1D). The per cent of absorbed

(GraphPad Prism, version 5.0). A Chi-square or Fisher's exact test

pups had a higher trend in the MNE group (8.1%) than the control

was used to analyse the incidence of CHDs and coronary artery

group (2.9%, p = 0.0548 by Fisher's exact test). Cardiac function

malformation. Two-way analysis of variance (ANOVA) followed by

of foetuses was assessed by echocardiography in utero at E18.5.

Tukey's multiple comparisons test were used for the analysis of sex

The ejection fraction and fractional shortening of the left ventricle

|
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TA B L E 1 The rate of congenital heart defects in the control and
MNE offspring

Nicotine (mg/kg/day)

Control

MNE

0

0.75

1.5

24/3

61/8

31/5

coronary artery malformation (Table 1). MNE dose-
dependently
increased the incidence of CHDs in foetuses from 0% in controls
to 13% and 33% in 0.75 and 1.5 mg/kg/day nicotine treatments,
respectively (p < 0.001). Figure 2A–J shows the typical examples
of ostium secundum ASD, perimembranous septum VSD, thick-

Congenital Heart Defects
n/litters

3227

ened pulmonary and aortic valves, and LV hypertrophy in the MNE
(1.5 mg/kg/day) group as well as corresponding normal controls.

n

%

n

%

n

%

Normal

31

100

21

87

38

67

Abnormal

0

0

3

13

20

33***

Atrial septal defect

0

0

2

8

4

13*

lar hypertrophy and no trabeculation in the RV in a P0 heart with

Ventricular septal
defect

0

0

0

0

1

2

MNE (1.5 mg/kg/day). Figure 2O–P shows a vestibular ASD,34 and

Double outlet right
ventricle

0

0

0

0

1

2

Hypoplastic left heart

0

0

1

4

0

0

Unguarded tricuspid
orifice

0

0

0

0

2

3

Thickened pulmonary
valve

0

0

0

0

5

8

Thickened aortic
valve

0

0

0

0

5

8

RV hypertrophy

0

0

1

4

5

8

LV hypertrophy

0

0

2

8

11

18**

Trabeculation defect

0

0

1

4

8

13*

nary artery and aorta were connected to the RV (Figure K and L).
Figure 2M–N shows an unguarded tricuspid orifice33 with ventricu-

a hypoplastic heart with ostium secundum ASD, aortic stenosis and

Coronary Artery Defects
n/litters

An E18.5 foetus with MNE had DORV in which both the pulmo-

15/5

24/3

61/8

hypoplastic left ventricle in the MNE (0.75 mg/kg/day) group. Both
pulmonary artery orifice diameter and aortic orifice area were significantly smaller while pulmonary valve thickness and the aortic valve
to total aortic orifice area ratio were significantly higher with MNE
(1.5 mg/kg/day) compared to the controls (Figure 2Q–T ), indicating
that outflow tract and semilunar valve remodelling35 are negatively
impacted by MNE at 1.5 mg/kg/day. No apparent abnormalities of
outflow tract and semilunar valves were seen with MNE 0.75 mg/
kg/day except one mouse that had aortic stenosis associated with
hypoplastic LV (Figure 2P).

3.3 | MNE induces hypoplastic coronary arteries
in mice

n

%

n

%

n

%

Normal

15

100

23

96

43

70

Coronary arteries were identified on E18.5 heart sections by α-

Abnormal

0

0

1

4

18

30***

smooth muscle actin immunostaining. Representative images of the

Note: Foetuses were examined at E17.5 to P0. n/litters indicate number
of foetuses and litters, respectively.

coronary arteries, and their abundance on 4-chamber view heart
sections are shown in Figure 3A–F. MNE (1.5 mg/kg/day) foetuses

Abbreviations: LV, left ventricle; RV, right ventricle.

had smaller diameters of left and right coronary arteries, and their

*p < 0.05, **p < 0.01, ***p < 0.001 vs. untreated control by chi-squared
test.

abundance was significantly lower (Figure 3G–I). 3D reconstructions
of the heart showed that the volume of the coronary artery tree was
significantly lower in MNE foetuses (Figure 3J–L). NME at 0.75 and
1.5 mg/kg/day induced 4% and 30% of coronary artery malforma-

(LV) were lower in the MNE group in comparison with control foe-

tion in foetuses, respectively (Table 1). Foetuses with both CHD and

tuses (p < 0.01, Figure 1E–F ), indicating reduced cardiac function

coronary artery malformation were 4% and 16% in 0.75 and 1.5 mg/

in nicotine-exposed foetuses. The sex of foetuses was identified

kg/day MNE, respectively.

by the Y chromosome specific gene using PCR analysis. Our data
showed that while the male to female ratio was about 50% in normal
foetuses, CHDs were more prevalent in males compared to females
(67% vs. 33%, p < 0.05, Figure 1G).

3.2 | MNE induces congenital heart defects in mice

3.4 | MNE changes gene expression in
foetal hearts
To study the effects of MNE (1.5 mg/kg/day) on the expression of
genes critical to embryonic heart development, foetal hearts were
collected at E10.5 and RT-qPCR analysis was performed. Changes

Foetuses from MNE developed CHDs ranging from atrial and ven-

in gene expression on pathways responsible for angiogenesis, cell

tricular sepal defects (ASD and VSD), double outlet right ventri-

proliferation, differentiation and EMT are summarized in Table 2.

cle (DORV), hypoplastic left ventricle, unguarded tricuspid orifice,

The mRNA levels of Hif1α, Bmp10, ALDH1a2, bFGF, Snail1, Slug, TGF-

trabeculation defect, thickened pulmonary and aortic valves to

β1, Notch1, eNOS, CyclinD1 and β-MHC were significantly lower in

3228
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(A)

(B)

(C)

(D)

(E)

(F)

(G)

(H)

(I)

(J)

(K)

(L)

(M)

(N)

(O)

(P)

(S)

(T)

(Q)

(R)

F I G U R E 2 Congenital heart defects (CHDs) in MNE offspring. A, C, E, G and I are normal morphology of heart structures in control
offspring. MNE (1.5 mg/kg/day) induced a spectrum of defects including (B) ostium secundum ASD, (D) thickened pulmonary valves, (F)
ostium secundum ASD and perimembranous septum VSD, (H) thickened aortic valves, (J) left ventricle hypertrophy, (K, L) double outlet
right ventricle (DORV) in which both pulmonary artery (K) and aorta (L) were connected to the RV (two different sections 350 μm apart
from the same heart) and (M, N) unguarded tricuspid orifice (absence of tricuspid valve, arrow heads) with no trabeculation of RV (two
different sections 300 μm apart from the same heart). MNE (0.75 mg/kg/day) induced (O) ostium primum ASD and (P) hypoplastic left heart
(HLH) with an ostium secundum ASD, aortic stenosis and hypoplastic LV. Q-T show effects of MNE (1.5 mg/kg/day) on pulmonary orifice
diameter (Q), total aortic orifice area (R), total pulmonary valve thickness (S), and aortic valve area to total aortic orifice area (T). Ao, aorta;
PA, pulmonary artery; RA, right atrium; LA, left atrium; LV, left ventricle; RV, right ventricle. All images are from E18.5 hearts. *p < 0.05,
**p < 0.01, ***p < 0.001 vs. untreated control by unpaired Student's t-test

|
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F I G U R E 3 Coronary artery
malformation in foetuses of MNE
(1.5 mg/kg/day). A, C and E are coronary
arteries in control foetuses. B, D and F
are coronary arteries of foetuses with
MNE. Arrows point to coronary artery
openings in E and F. Quantification of left
and right coronary artery diameter, and
abundance (G, H and I, respectively). J
and K are examples of 3D reconstructions
of coronary arteries in control and MNE
foetuses, respectively. The volume of
coronary arteries was significantly lower
in MNE foetuses (L). All images are from
E18.5 hearts. **p < 0.01, ***p < 0.001 vs.
untreated control by unpaired Student's t-
test. LCA, left coronary artery; RCA, right
coronary artery; CA, coronary artery; LV,
left ventricle; RV, right ventricle

(A)

(B)

(G)

(C)

(D)

(H)

(E)

(J)

(F)

(K)

3229

(I)

(L)

MNE hearts in comparison with the controls (p < 0.05), while no

significantly lower in the ventricular myocardium of the MNE

significant changes were found in Tbx18, Gata4, Nkx2.5, PKCi or

(1.5 mg/kg/day) group in comparison with the control group

Tbx5 mRNA levels (Table 2).

(p < 0.01, Figure 4C).

To determine signalling pathways on cardiac hypertrophy
during later stages of heart development, gene expression was
assessed in E18.5 hearts using RT-qPCR analysis. The levels TGF-
β1, CyclinD1, β-M HC and BNP mRNAs were significantly higher

3.6 | Nicotine exposure inhibits epicardial EMT
ex vivo

in MNE hearts (1.5 mg/kg/day) in comparison with the controls
(p < 0.05, Table 2).

Epicardial EMT is essential to coronary artery development. To
study the effect of nicotine on epicardial EMT, E12.5 heart explants

3.5 | MNE lowers cell proliferation

were seeded on collagen coated wells to allow epicardial cell outgrowth and EMT to become spindle-shaped, mesenchymal like cells
(Figure 4D–F ). The area of outgrowth and the number of spindle-

Cell proliferation is critical to heart morphogenesis and coronary

shaped cells were quantified and normalized to heart explant area

artery development. E10.5 hearts were immunostained with the

(Figure 4G,H). Nicotine-treated heart explants showed significantly

phosphorylated histone H3 (pHH3), a biomarker of proliferating

less outgrowth and fewer spindled-shaped cells in comparison with

cells (Figure 4A,B). The pHH3 positive cells were quantified on

the controls (p < 0.05, Figure 4G,H). These data suggest that nico-

4–5 sections per heart. The number of pHH3 positive cells was

tine exposure inhibits epicardial EMT of the foetal heart.

3230
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TA B L E 2 Gene expression of transcription and growth factors
critical to heart and coronary morphogenesis in E10.5 hearts and
hypertrophic growth factors in E18.5 hearts of fetuses from MNE
(1.5 mg/kg/day) and control groups

significantly higher levels of lipid peroxidation in comparison to the
control group (p < 0.001, Figure 5H).

Control

MNE

4

|

DISCUSSION

E10.5
Hif1α

0.00219 ± 0.00032

0.00134 ± 0.00018*

Defining safety guidelines of substance use during pregnancy is a

Bmp10

0.00925 ± 0.00108

0.00359 ± 0.00042***

critical focus in preventative healthcare to lower the incidence of

ALDH1a2

0.02157 ± 0.00308

0.00997 ± 0.00238*

congenital defects. A risk factor such as MNE could be controlled

bFGF

0.00431 ± 0.00053

0.00240 ± 0.00033*

Snail1

0.00069 ± 0.00012

0.00036 ± 0.00005*

Slug

0.00050 ± 0.00008

0.00022 ± 0.00005*

TGF-β1

0.01648 ± 0.00228

0.01037 ± 0.00121*

Notch1

0.00035 ± 0.00003

0.00019 ± 0.00002*

eNOS

0.00606 ± 0.00091

0.00336 ± 0.00031*

Tbx18

0.00080 ± 0.00011

0.00061 ± 0.00012

Cyclin D1

0.00213 ± 0.00036

0.00127 ± 0.00016*

β-MHC

0.04210 ± 0.00614

0.01688 ± 0.00305**

is vital to determine mechanisms underlying MNE’s effects on foetal

Gata4

0.02638 ± 0.00509

0.01977 ± 0.00363

hearts during crucial developmental stages. Our data provide evi-

Nkx2.5

0.00357 ± 0.00059

0.00322 ± 0.00053

dence that MNE impairs cell proliferation and epicardial EMT during

PKCi

0.00315 ± 0.00032

0.00296 ± 0.00067

embryonic development. In E10.5 hearts, when cardiac septation,

Tbx5

0.00327 ± 0.00069

0.00209 ± 0.00031

TGFβ1

0.01179 ± 0.00071

0.01506 ± 0.00109*

Cyclin D1

0.00982 ± 0.00079

0.01384 ± 0.00117*

β-MHC

1.03500 ± 0.09925

1.45000 ± 0.12770*

BNP

0.02433 ± 0.00223

0.03266 ± 0.00256*

E18.5

Note: RT-qPCR analysis of mRNA levels in relation to 28S ribosomal
RNA in E10.5 and E18.5 ventricular myocardium. Data are mean ±SEM.
*p < 0.05 **p < 0.01, ***p < 0.001 vs. untreated control by unpaired
Student's t-test, n = 7–8 per group.

3.7 | MNE increases oxidative stress in
foetal hearts

by establishing updated guidelines for NRT use during pregnancy.
Therefore, we evaluated MNE’s effects on heart development and
underlying pathways. MNE dose-dependently induced both CHDs
and altered coronary artery development in the foetuses of mice.
MNE resulted in higher ROS levels in developing hearts. High ROS
levels contribute to CHDs and malformation of coronary arteries
in mouse offspring.36 We established for the first time a model of
CHDs induced by MNE in mice.
To determine CHD pathogenesis and coronary artery defects, it

chamber valve formation and coronary artery genesis begins. Less
cell proliferation was found in foetuses of MNE than those of the
control mice. Also, fewer pHH3-stained cells in these hearts indicate
less proliferation than those of control hearts. Mechanisms of lower
proliferation with MNE were indicated by gene expression analysis. Foetal hearts of MNE mice had significantly lower expressions
of CyclinD1, bFGF, Bmp10 and β-MHC, markers of cardiomyocyte
growth and proliferation.
Notably, the mRNA level of Hif1α, an important controller of
epicardial EMT, including the myocardial migration of EPDCs,37 was
lower in the MNE mouse foetuses than those of control foetuses.
ROSs alter Hif1αexpression. Lower ROS levels cause higher Hif1α
expression, which promotes cardiovascular differentiation. On the
other hand, higher levels of ROS inhibit Hif1α expression.38 Other
important genes for EMT include Snail1, Slug, bFGF, eNOS, Notch1

To assess the effect of MNE on oxidative stress in foetal hearts,

and ALDH1a2, their mRNA levels were all lower with MNE. Snail1,

superoxide levels were determined in E10.5 hearts using dihydro-

Slug and ALDH1a2 are all downstream of Hif1α, while Notch1 acti-

ethidine (DHE) as a probe. To verify that the DHE fluorescence was

vates the expression of Snail1, Slug and TGFβs.39 ALDH1a2 promotes

superoxide, some heart sections were incubated with a superoxide

retinoic acid signalling that is essential for the formation of the epi-

scavenger, superoxide dismutase (SOD). Fluorescence images were

cardium, its attachment to the myocardium, subsequent growth and

taken on 5 sections per heart for all groups at the same exposure,

proliferation, and the development of the coronary arteries.39,40

and intensity of the fluorescence was quantified using densitometry

bFGF mediates retinoic acid signalling, in embryonic hearts, promot-

(Figure 5A–D). The results showed that hearts with MNE (1.5 mg/

ing EMT and vasculogenesis. In our study, MNE lowers bFGF expres-

kg/day) had significantly higher superoxide levels than the con-

sion and impairs signalling of Snail1/Slug and ALDH1a2/bFGF, which

trol group (p < 0.05), which was attenuated by SOD (p < 0.001,

will result in lower epicardial EMT and coronary artery malforma-

Figure 5G).

tions in foetal hearts.

To assess oxidative damage, levels of 4-hydroxynonenal, a prod-

Lower cell proliferation at E10.5 does not explain the ventric-

uct of lipid peroxidation were determined in E10.5 hearts using

ular hypertrophy in many MNE E18.5 foetuses in our study. To

immunostaining. Fluorescence images were taken at the same ex-

gain insights into underlying molecular mechanisms, expression of

posure on 5 sections per heart in control and NME (1.5 mg/kg/day)

various hypertrophic genes was evaluated in E18.5 foetal hearts.

groups (Figure 5E,F). Our data showed that the MNE hearts had

TGF-β1, β-MHC, BNP and Cyclin D1 had higher expressions in MNE
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F I G U R E 4 Effects of nicotine on
cell proliferation and epicardial EMT.
A-C , MNE (1.5 mg/kg/day) inhibits cell
proliferation of foetal hearts in vivo. A and
B are representative images of phospho-
histone H3 (pHH3) immunostaining of
heart sections from control and MNE
foetuses at E10.5, respectively. C,
Quantification of pHH3-positive cells
per mm2 in E10.5 hearts. D-H, Nicotine
decreases epicardial EMT ex vivo. D-F,
E12.5 heart explants were seeded on
collagen coated wells in the presence or
absence of nicotine (100 ng/ml). Epicardial
cells migrated from the heart explant
and underwent EMT to become spindle-
shaped, mesenchymal like cells. Four days
after nicotine incubation, cell outgrowth
area (G) and spindle-shaped cell
numbers (H) were quantified. **p < 0.01,
***p < 0.001 compared to controls by
unpaired Student's t-test

(A)

(B)
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(C)

(D)

(E)

(F)

(H)

(G)

hearts than those of control hearts. In utero cardiac hypertrophy is

Increased intracellular Ca2+ in the foetus causes mitochondrial

due to cardiomyocyte proliferation and hypertrophy.41 Cyclin D1

production of ROS production.48 Increased mitochondrial ROS

42

production disrupts the endogenous antioxidant capacity which

Increased ventricular β1 are associated with cardiac hypertro-

can lower cell proliferation.36 During embryonic development, high

has important roles for proliferation and hypertrophic regulation.
phy.

43,44

phy.

45

Upregulation of β-MHC is a marker of cardiac hypertro-

ROS produces DNA damage, and oxidation of proteins and lipids,

Our results in mice support the conclusion that MNE causes

as well as affecting cellular apoptosis, proliferation, differentiation

ventricular hypertrophy. Additionally, haemodynamic expressions

and inflammation.36 Increased ROS also reduces nitric oxide bio-

of BNP and TGF-changes due to thickened semilunar valves, nar-

availability and eNOS coupling.30 eNOS deficiency leads to CHDs

rowed orifice of the aorta and pulmonary artery, and septal defects

and malformations of the coronary arteries.49,50 Also, ROS regulates

may also contribute to ventricular hypertrophy in MNE hearts.

vasculogenesis.51 Physiological levels of ROS promote normal vessel

Excessive production of ROS has been shown to be detrimen-

development; however, excessive ROS during cardiac development

tal to embryogenesis, and oxidative stress promotes the develop-

inhibits vessel development.36 Our results support that higher lev-

ment of CHDs.

26,36

In our study, MNE hearts at E10.5 had higher

superoxide and lipid peroxidation levels, indicating oxidative dam-

els of ROS contribute to CHDs and coronary artery malformation in
MNE mouse offspring.

age.46 Nicotine binding to nicotinic acetylcholine receptors results

Dose-dependent higher CHDs in offspring of MNE indicate nic-

in increased ion influx, which increases intracellular Ca2+ and sub-

otine levels enhance cardiac malformations. A cigarette contains

sequently disturbs intracellular signalling and organelle function.47

0.8–1.9 mg of nicotine on average and typically results in 10–50 ng/

3232
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(A)

(B)

(C)

(D)

(E)

(F)

(G)

F I G U R E 5 Effects of MNE (1.5 mg/
kg/day) on oxidative stress. A and B are
representative images of dihydroethidium
(DHE) stained heart sections to assess
superoxide levels in control and MNE
foetuses at E10.5, respectively. Tissues
were incubated with superoxide
dismutase (SOD) to verify superoxide
specific signals in control (C) and MNE
(D) foetal heart sections. G, the intensity
of DHE fluorescence was quantified
by densitometry. *p < 0.05 vs control,
††p < 0.01 vs MNE without SOD using
two-way ANOVA followed by Tukey's
multiple comparisons test. E and F,
E10.5 heart sections were immunostained
using an anti-4-hydroxynonenal (4-HNE)
antibody to assess lipid peroxidation in
control and MNE foetal hearts. H, the
intensity of 4-HNE fluorescence was
quantified by densitometry. ***p < 0.001
vs control by unpaired Student's t-test

(H)

ml peak plasma levels in humans with a plasma half-life of less than

excess ROS levels induced by MNE alter genetic expression pro-

20 min and a distribution volume 2.6 times body weight, indicating

files, cellular proliferation and EMT, leading to the development of

nicotine quickly gets into the tissues after smoking. 28,29 Plasma half-

CHDs and coronary artery malformation. These findings elucidate

life of nicotine is less than 7 min in mice.52 A limitation of our study

the adverse effects of nicotine use in women during pregnancy. Our

is that we were unsuccessful in measuring plasma nicotine levels in

model provides a future opportunity to further dissect mechanisms

pregnant mice. Thus, we are unable to correlate plasma nicotine lev-

of MNE-induced CHDs.

els with CHDs. Also, we did not implant osmotic pumps in control
mice, which may interfere with pregnancy. However, female mice

AC K N OW L E D G E M E N T S

were bred 14 days after pump implantation. Thus, any adverse ef-

This work was performed in partial fulfilment of the requirements

fect of the surgery or pump on pregnancy would be minimal.
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In conclusion, in mice, MNE dose-dependently induces CHDs
and malformations of the coronary arteries. In embryonic hearts,

Physiology and Pharmacology, University of Western Ontario,
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